TSH receptor antibodies, which may be stimulatory or blocking, play an
important role in the pathogenesis of Graves' disease and Hashimoto's
thyroiditis, respectively. In recent years, the ability to accurately
and reproducibly measure TSH receptor antibodies in clinical circumst
ances has improved, and their measurement may alter the diagnostic and
therapeutic approach to such patients. The purpose of the present rev
iew is to discuss the measurement techniques, utility, pitfalls, and l
imitations of TSI-I receptor antibody assays. The measurement of TSH r
eceptor antibody levels can be used to help predict the recurrence of
Graves' disease, to help diagnose Graves' ophthalmopathy, and to deter
mine the likelihood that neonatal Graves' disease will occur. TSH rece
ptor blocking antibodies are useful in determining the clinical manife
stations of hypothyroidism.